- Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
Breast Cancer Res 13:R67. 2011..We assessed the prognostic impact of CTCs according to different first-line systemic treatments, and explored their potential predictive value in MBC patients...
- Urinary beta2-microglobulin masquerading as a Bence Jones proteinB C Handy
Department of Laboratory Medicine, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Arch Pathol Lab Med 125:555-7. 2001..A case is described in which a high urinary concentration of beta2-microglobulin interfered with Bence Jones protein quantification by electrophoresis studies...